|
TM7SF3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.170230E-04 |
| Normal-vs-Stage3 |
7.19760029355143E-10 |
| Normal-vs-Stage4 |
9.87219999970534E-07 |
| Stage1-vs-Stage2 |
3.429000E-01 |
| Stage1-vs-Stage3 |
5.755600E-01 |
| Stage1-vs-Stage4 |
5.305600E-01 |
| Stage2-vs-Stage3 |
6.246200E-01 |
| Stage2-vs-Stage4 |
2.465400E-01 |
| Stage3-vs-Stage4 |
3.564400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.76439999999278E-06 |
| Normal-vs-Asian |
6.57989995822561E-09 |
| Caucasian-vs-AfricanAmerican |
2.238600E-01 |
| Caucasian-vs-Asian |
9.379600E-01 |
| AfricanAmerican-vs-Asian |
1.985420E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.06590292148212E-11 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
8.669000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
1.07647224467655E-12 |
| Normal-vs-Age(61-80Yrs) |
2.50400000734174E-09 |
| Normal-vs-Age(81-100Yrs) |
4.075600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.970190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.350600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.694800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.548400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.999400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.302600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.796300E-02 |
| Classical-VS-Follicular |
3.989700E-02 |
| Classical-VS-Other |
3.532600E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
9.989800E-01 |
| Tall-VS-Other |
7.350600E-01 |
| Tall-VS-Normal |
1.57064999999346E-05 |
| Follicular-VS-Other |
8.300200E-01 |
| Follicular-VS-Normal |
2.07029999998998E-06 |
| Other-VS-Normal |
1.596150E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.08577599636328E-12 |
| Normal-vs-N1 |
2.03239999999605E-05 |
| N0-vs-N1 |
7.062400E-01 |
|
|
